PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|June 2, 2014
- Pharmaceutical Technology-06-02-2014
- Volume 38
- Issue 6
Centrifuges Increase Capacity and Flexibility
Author(s)Melanie Sena
Centrifuges Increase Capacity and Flexibility
Thermo Scientific’s general purpose centrifuges feature increased capacity and flexibility with rotor improvements including the Thermo Scientific TX-1000 rotor, which employs a 4-liter capacity in a traditional 3-liter footprint. Additionally, the MicroClick 30 x 2 rotor offers a 30-place capacity for microtube and nucleic acid spin columns, and is used for molecular biology applications. According to the company, these high-capacity rotors are designed to process more tubes in fewer runs, saving time while reducing wear on the centrifuge. The general purpose centrifuge floor models conserve bench space with a 25% smaller footprint compared to refrigerated benchtop models and a working height of 79 cm, providing ergonomic design for removing tubes and exchanging rotors.
Articles in this issue
over 12 years ago
Selecting a Specimen Holder for X-ray Powder Diffractionover 12 years ago
Single-Use Mixing System Improves Performanceover 12 years ago
Global Expansion Shapes Drug Oversightover 12 years ago
Regulating the Environmental Impact of Pharmaceuticalsover 12 years ago
Is a Sample Size of n=6 a 'Magic' Number?over 12 years ago
Hybrid Purifer Enhances Efficiencyover 12 years ago
Advances in Controlled-Release Drug Deliveryover 12 years ago
Brunei's Potential Pharmaceutical Market Growthover 12 years ago
Outsourcing No Longer Just for Cost-Cuttingover 12 years ago
Packaging Innovations AboundRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.